The ChiNext Index's initial gains expanded to 1%, and the Shanghai Composite Index rose 0.15%; major pharmaceutical concepts rebounded collectively, with concepts such as CRO, innovative drugs, monoclonal antibodies, and recombinant proteins strength

2025-07-08

The ChiNext Index's initial gains expanded to 1%, and the Shanghai Composite Index rose 0.15%; major pharmaceutical concepts rebounded collectively, with concepts such as CRO, innovative drugs, monoclonal antibodies, and recombinant proteins strengthening; about 3,800 stocks in the city rose, 1,300 stocks fell, and the net outflow of major funds exceeded 2 billion yuan.